Stay informed of the latest progress in canine health research.
We need your support to fund research that helps dogs live longer, healthier lives.
Hyperadrenocorticism in dogs is caused by problems with the adrenal system that lead the overproduction of one or more hormones. Symptoms are many. Some of the most common include excessive hunger and thirst, a need to urinate frequently, poor heat tolerance, skin problems, and muscle weakness. However, the specific symptoms of hyperadrenocorticism vary both by the dog and by which hormones are affected, which can sometimes make it difficult to diagnose and treat.
Although veterinarians are generally familiar with the most common presentation of hyperadrenocorticism, where levels of the stress hormone cortisol are increased, there is less understanding of a condition known as atypical hyperadrenocorticism. Dogs with this disease actually have normal levels of cortisol but show increased levels of various other steroid hormones – including the sex hormones estradiol and progesterone. These hormones are produced not just in the adrenal gland, but throughout the body, which can significantly complicate treatment.
However, there is hope. With the help of the AKC Canine Health Foundation, scientists from the University of Tennessee, Knoxville have begun to look for a treatment that could effectively help dogs with the atypical form of hyperadrenocorticism. Working with cultured human adrenal tumor cells, since canine cell lines aren’t available, they have identified a combination of two compounds – melatonin and lignan – which in preliminary studies looks like they might be able to bring many cases of atypical hyperadrenocorticism under control.
When the two substances were combined and applied to adrenal tumor cells, the scientists were pleased to discover that the treatment did largely what they’d hoped. It reduced the amounts of cortisol, estradiol, and androstenedione, three important hormones, as well as the amount of aromatase, which plays an important role in hormone synthesis. Those results strongly suggested that the treatment might prove useful for some dogs with atypical hyperadrenocorticism, although it’s probably not the answer for all. Unfortunately, melatonin and lignan treatment actually increased progesterone and 17-hydroxyprogesterone production by cells, and veterinarians would probably not want to use this treatment for dogs whose condition was caused by problems with those hormones.
This work was funded by AKC Canine Health Foundation grant 844-A.
Learn about research funding opportunites and submission procedures.
You can make contributions to support the specific areas of research that match your interests or greatest health concern.
Your help is needed with canine health research. DNA and tissue samples are needed from healthy dogs and dogs affected by certain diseases.